Brilinta for Prevention in T2D; Pacer Recall; PCSK9 for Statin Myopathy Cases
MedPage Today Recent developments of interest in cardiovascular medicine
View ArticleSanofi Sanofi and Regeneron strongly disagree with verdict upholding three of...
Sanofi and Regeneron strongly disagree with verdict upholding three of five Amgen U.S. patent claims relating to PCSK9 antibodies Praluent alirocumab continues to be available in the U.S. PARIS and...
View ArticleStatin Deprescribing Followup How You Voted
Did readers agree with Dr Vega on whether to deprescribe an elderly patient's statin Medscape Family Medicine
View ArticlePCSK9 inhibitors found to lower cholesterol in case reports of patients with...
1. In this case report two patients who developed statinassociated autoimmune myopathy had their cholesterol levels effectively managed with the novel cholesterol reduction medication evolocumab. 2....
View ArticleDrugs to Lower BP Cholesterol Don't Seem to Slow Cognitive Decline in Most
A statin and an angiotensinreceptor blocker don't appear to slow cognitive decline in most elders according to a subanalysis from the HOPE3 trial...
View ArticleStatin Adherence and Death Rates Critical Data
Nonadherence is associated with mortality a large observational study reveals.
View ArticleYour NEJM Group Today What's Next for Genome Editing Consequences of Statin...
Take a look at the latest from NEJM Group NEJM Audio Interview What's Next for Genome Editing Dr. George Daley discusses the prospects for using...
View ArticleRecommendations for Treatment of Hypercholesterolemia in Older Adults
This Viewpoint discusses the 2018 ACCAHA cholesterol management guideline recommendation to consider statin treatment in adults aged >75 years with LDL levels 70189 mgdL arguing that trial...
View ArticleAdding Bempedoic Acid to Statin Therapy Reduces LDL Cholesterol
WEDNESDAY March 13 2019 Bempedoic acid an inhibitor of ATP citrate lyase ACLY added to maximally tolerated statin therapy significantly reduces levels of lowdensity lipoprotein LDL cholesterol in...
View ArticleNew Drug Could Help Those With ToughtoTreat Cholesterol
THURSDAY March 14 2019 People whose high cholesterol is resistant to treatment with statin drugs may soon have a new treatment option.This new class of drugs helps block synthesis of arteryclogging...
View ArticleNew Trial Drug Bempedoic Acid Could Help Those With ToughtoTreat Cholesterol
THURSDAY March 14 2019 People whose high cholesterol is resistant to treatment with statin drugs may soon have a new treatment option.This new class of drugs helps block synthesis of arteryclogging...
View ArticleStatin addon may offer newanother option for reducing LDLC in highrisk patients
American College of Cardiology Patients at high risk for a heart attack or stroke who took an investigational drug in addition to a statin had significantly lower LDL or 'bad' cholesterol after 12...
View ArticlePure Omega3 prescription drug markedly reduces first repeat and total CV events
American College of Cardiology Taking a high dose of icosapent ethyl a pure and stable prescription form of the omega3 fatty acid known as EPA significantly reduces the occurrence of first subsequent...
View ArticleSTAT Plus New results show benefits of Esperions cholesterol drug but leave...
A drug maker is hoping that its experimental drug can be used in patients who cant take a statin because of side effects. ACC19
View ArticleSTAT Plus A drug maker is hoping that its experimental drug can be used in...
STAT Plus A drug maker is hoping that its experimental drug can be used in patients who can’t take a statin because of side effects. ACC19 httpsbuff.ly2Jm8gui
View ArticleStatin Use Tied to Lower ColorectalCancer Risk After Negative Colonoscopy
Statin use is associated with a reduced risk of colorectal cancer between six and 36 months after an initial negative colonoscopy according to a retrospective study. Reuters Health Information
View ArticleResearch Pure omega3 prescription drug significantly reduces the occurrence...
Taking a high dose of icosapent ethyla pure and stable prescription form of the omega3 fatty acid known as EPAsignificantly reduces the occurrence of first subsequent and total ischemic events...
View ArticleACC Icosapent Ethyl Beneficial for StatinTreated Patients
TUESDAY March 19 2019 For statintreated patients with elevated triglycerides and established cardiovascular disease or diabetes icosapent ethyl is associated with a reduced rate of total primary end...
View ArticlePhysicians Education Resource Presents Cutting CVD Risk by Adding PCSK9...
This live symposium will be held adjunct to the 2019 American College of Physicians Internal Medicine Meeting Physicians Education Resource PER a worldwide leader in continuing medical education CME...
View ArticleWhy Patients Aren't on Statins
Most statineligible patients who go untreated say they've never been offered treatment according to an industrysupported study in the Journal of the American...
View Article